← FDA Drug Approvals (Drugs@FDA)
DOCETAXEL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HENGRUI PHARMA · Approved 2017-08-09
Drug application
- FDA Application #
ANDA207252- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOCETAXEL
- Generic name
- DOCETAXEL
- Active ingredients
- DOCETAXEL
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- HENGRUI PHARMA
- Manufacturer
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- First approval
- 2017-08-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown